Bank of New York Mellon Corp Makes New $308.64 Million Investment in Cardinal Health, Inc. $CAH

Key Points

• Bank of New York Mellon acquired 1.3 million Cardinal Health shares worth approximately $308.64 million, giving it a 0.55% stake. Institutional investors collectively own 87.17% of the company.
• Cardinal Health reported quarterly adjusted EPS of $2.91, beating estimates of $2.42, while revenue rose 5.8% year over year. Analysts remain positive, with a “Moderate Buy” consensus rating and an average price target of $266.56.
• Several insiders sold substantial holdings, including CEO Stephen Mason’s $8.27 million sale, contributing to roughly $49.6 million in insider sales over the past 90 days. The company also declared a quarterly dividend of $0.5158 per share, yielding about 0.9% annually.

Bank of New York Mellon Corp acquired a new position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) in the second quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 1,299,209 shares of the company's stock, valued at approximately $308,640,000. Bank of New York Mellon Corp owned 0.55% of Cardinal Health as of its most recent filing with the SEC.

Several other institutional investors have also recently added to or reduced their stakes in the stock. University of Texas Texas AM Investment Management Co. acquired a new stake in shares of Cardinal Health in the fourth quarter valued at $26,000. Bank of Jackson Hole Trust acquired a new position in Cardinal Health during the 4th quarter worth about $27,000. Jones Financial Companies Lllp boosted its holdings in Cardinal Health by 198.3% during the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company's stock valued at $27,000 after acquiring an additional 14,034 shares during the period. Palladiem LLC purchased a new position in Cardinal Health during the 4th quarter valued at about $28,000. Finally, Indiana Trust & Investment Management Co acquired a new position in Cardinal Health in the 1st quarter valued at about $29,000. Institutional investors and hedge funds own 87.17% of the company's stock.

Insider Buying and Selling at Cardinal Health

In related news, CEO Stephen M. Mason sold 35,000 shares of the business's stock in a transaction dated Tuesday, August 18th. The shares were sold at an average price of $236.40, for a total transaction of $8,274,000.00. Following the sale, the chief executive officer owned 18,061 shares of the company's stock, valued at approximately $4,269,620.40. The trade was a 65.96% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Michelle D. Greene sold 11,650 shares of the company's stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $235.72, for a total transaction of $2,746,138.00. Following the transaction, the insider owned 10,330 shares in the company, valued at $2,434,987.60. The trade was a 53.00% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders sold 210,271 shares of company stock worth $49,626,657. Company insiders own 0.12% of the company's stock.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on CAH shares. Wall Street Zen raised shares of Cardinal Health from a "buy" rating to a "strong-buy" rating in a research note on Saturday, July 4th. Wells Fargo & Company raised their price target on shares of Cardinal Health from $245.00 to $277.00 and gave the company an "overweight" rating in a research report on Wednesday, August 12th. Bank of America boosted their price target on shares of Cardinal Health from $240.00 to $260.00 and gave the stock a "buy" rating in a research note on Thursday, July 2nd. William Blair assumed coverage on Cardinal Health in a research report on Tuesday, April 28th. They set an "outperform" rating on the stock. Finally, Evercore reiterated an "outperform" rating and issued a $270.00 price objective on shares of Cardinal Health in a research note on Wednesday, August 12th. Sixteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $266.56.

Key Stories Impacting Cardinal Health

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Royal Bank of Canada initiated coverage with an “outperform” rating and a $276 price target, implying meaningful upside from recent trading levels. RBC cited Cardinal Health’s higher-margin services as a potential earnings-growth driver. RBC initiates coverage of Cardinal Health
• Positive Sentiment: Wall Street remains broadly constructive, with 16 analysts rating CAH a Buy and three assigning a Hold rating. The consensus rating is “Moderate Buy,” with an average price target of approximately $266.56. Zacks also identified Cardinal Health as a potentially attractive long-term value stock. Zacks value-stock analysis
• Positive Sentiment: Cardinal Health’s latest quarter delivered adjusted earnings per share of $2.91, well above the $2.42 consensus estimate, while revenue increased 5.8% year over year. Fiscal 2027 EPS guidance of $12.40–$12.60 supports the longer-term earnings case.
• Neutral Sentiment: The company declared a quarterly dividend of $0.5158 per share, equivalent to $2.06 annually and a yield of about 0.9%. The payout offers modest income support but is unlikely to be a major near-term catalyst.
• Negative Sentiment: Several executives sold sizable holdings around $235–$237 per share. CEO Jason Hollar sold 124,529 shares worth about $29.4 million, while other executive and insider sales—including those by Deborah Weitzman, Stephen Mason, Michelle Greene, Jessica Mayer and Mary Scherer—totaled roughly $20 million more. The concentrated selling and substantial reductions in insider ownership may encourage profit-taking concerns after CAH’s strong advance. Cardinal Health insider sales
• Negative Sentiment: Investors may also question the durability of the latest earnings beat because part of the improvement reportedly reflected a one-time tariff refund, potentially limiting the stock’s upside if recurring earnings growth does not match expectations. Cardinal Health earnings analysis

Cardinal Health Stock Performance

Shares of Cardinal Health stock opened at $229.48 on Friday. The company has a market capitalization of $53.37 billion, a P/E ratio of 31.74, a PEG ratio of 1.22 and a beta of 0.49. Cardinal Health, Inc. has a 1 year low of $145.87 and a 1 year high of $258.30. The company's fifty day moving average is $232.02 and its two-hundred day moving average is $217.86.

Cardinal Health (NYSE:CAH - Get Free Report) last announced its quarterly earnings data on Tuesday, August 11th. The company reported $2.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.42 by $0.49. The company had revenue of $63.67 billion for the quarter, compared to analysts' expectations of $65.15 billion. Cardinal Health had a net margin of 0.67% and a negative return on equity of 98.53%. Cardinal Health's revenue was up 5.8% compared to the same quarter last year. During the same period in the previous year, the company posted $2.08 EPS. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. As a group, equities analysts expect that Cardinal Health, Inc. will post 12.54 earnings per share for the current year.

Cardinal Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, October 15th. Shareholders of record on Thursday, October 1st will be given a dividend of $0.5158 per share. This represents a $2.06 annualized dividend and a dividend yield of 0.9%. The ex-dividend date is Thursday, October 1st. Cardinal Health's payout ratio is presently 28.49%.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company's core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source